Gedela Srinubabu

Srinubabu completed his PhD from Andhra University and his post-doctorate from Stanford University. In 2007, he received the Young Scientist Award from Human Proteome Organization in Seoul, South Korea.[14][8][15]

Srinubabu has published research articles on how to study biological phenomena using Mathematical model, and how to detect cancer or diabetes early. He has published about 30 articles in various peer-reviewed journals. According to Google Scholar Dr. Gedela Srinubabu Scientific h-index 13, i10-index 19.[16]

Journals that publish scientific research material in various fields traditionally generate income in the form of journal subscriptions. Scientists receive articles from authors for free, peer-review them, and publish them. Thus they get income from the subscribers of their magazines. Srinubabu took up publications in exactly the opposite way.[17] He followed the practice of collecting a fee from the writers and publishing their articles and giving them to the readers for free. This is called open-access publishing.[18] Thus, within a short period of time, he started publishing journals on many scientific subjects. In traditional journals, it takes months for articles to go through review, corrections, etc., before publication. This new method will be published within a few weeks. Researchers can pay a small amount of money to conduct an expedited review and publish their publication quickly.

Yearly, Pulsus Group publishes more than 50,000 research articles,[19] and organizes more than 3,000 conferences every year around the world, bringing scientists together through their conferences, discussing scientific and technological research results, and contributing to the exchange of information.[20] Currently, the Pulsus Group operates out of six Special Economic Zones with over 5000 employees, headquartered in Hyderabad, Chennai and Delhi. 75% of them are women.[21]

Gedela Srinubabu as FABA Vice President for China-India Bilateral

In 2013, Srinubabu served as the Vice President of the Federation of Asian Biotech Association (FABA) to improve the global trade, BS Bajaj said that the representation and services of Gedela is crucial in increasing FABA's global growth.[1][22] In 2019, Srinubabu worked for Bilateral investment treaty of India and China.[23][24]

Belgium Embassy delegates and European delegation team visited the Pulsus Group office in Hyderabad in 2018 to sign an agreement to establish a Pulsus center in Belgium.[25] At the 2019 Thessaloniki International Fair (TIF) held in Greece, Srinubabu along with Indian Union Minister Hardeep Singh Puri participated as Indian delegation and met with the Prime Minister of Greece, Kyriakos Mitsotakis to discuss the translation of health care and agriculture information into regional languages.[2][26][27]

Gedela Srinubabu - Indo American Chamber of Commerce 2022

Since 2013, US-based blogger Jeffrey Beall has used his personal blog, scholarlyoa.com, to criticise the publishing practises of Omics Group and Srinubabu. Through his blog, allegations were made against Omics regarding the quality of its scientific journals and its business practises.[28][29] Omics files a lawsuit against Jeffrey Beall, seeking damages of $1 billion.[30] Effective January 2017, Jeffrey Beall resigned from his services at Colorado University and shut his blogs. However, no further follow-up was made about damages of $1 billion in legal affairs.[31]

In 2016, based on blog postings by Beall, the Trade Commission of the United States filed a lawsuit against Omics publishing practices, citing their detrimental effects on American publisher's loss of trade to the United States. If 10,000 articles article is published in open access journals, the publication cost is about $10 million with an average $2000 article processing cost, depending on the open-access journal publisher's model, and if the same 10,000 articles are published under a subscription business, they can generate about $500 million annually by giving subscriptions to thousands of universities and research institutions across the world. Subscription models are followed by the majority of Western publishing companies, including academic publishing companies of United States.[32][33] In April 2019, the court imposed a fine of US$50.1 Million on Omics companies.[34][35][36] Omics' lawyer said that this was an unfair allegation and that Omics had sued the US Federal Trade Commission for $3.11 billion in damages, saying it had caused loss of revenue and reputation.[35][37] Srinubabu commented on the case filed by the Federal Trade Commission. "The Federal Trade Commission's allegation is completely wrong... They don't know what a journal is. Don't know what peer review is. They are illiterate in this matter. But scientists are not illiterate, they know which article to publish in which journal."[37]

The party announced Srinubabu as the Jana Sena candidate for the Visakhapatnam parliamentary constituency in the 2019 general elections [38] But after two or three days, Srinubabu left the party and joined the YSR Congress party.[39]

In 2018 Srinubabu visited areas affected by Cyclone Titli and observed distribution of food, blankets and clothing.[40][41][42] His organization has donated one crore rupees to Government of Andhra Pradesh, twenty five lakh rupees to Government of Telangana and distributed masks and sanitizers in various districts for the relief of coronavirus during the COVID-19 pandemic in India,[43][44] and also donated Rs 20 lakhs to Ram Mandir construction.[45]

Dr Srinubabu Gedela Champions of Change Award from Vice President of India

Srinubabu received the Pride of the Nation Award in 2019,[21] and the Government of India Champions of Change 2018 award.[46]

Srinubabu is the owner of Vizag Warriors, of the Andhra Premier League T20 cricket league in Andhra Pradesh.[47][48][49]

Indian actor, producer and businessman Ram Charan has invested in the team with Srinubabu, aiming to get the team promoted to the IPL in 2024.[50][51]